In a report released today, Srikripa Devarakonda from Truist Financial maintained a Buy rating on AbbVie (ABBV – Research Report). The company’s shares closed yesterday at $201.68. Devarakonda ...

Pharmaceutical company AbbVie (ABBV) is the latest stock in my portfolio to announce a higher dividend. Accompanying its third-quarter earnings report, AbbVie declared a 5.8% increase in its ...

Each month, we take a close look at an aspect of sector investing. This month, we are examining growth and valuation. Investors hunting for stocks that reasonably balance long-term growth ...

In recent trading, shares of AbbVie Inc (Symbol: ABBV) have crossed above the average analyst 12-month target price of $202.46, changing hands for $203.87/share. When a stock reaches the target an ...

In this article, we are going to take a look at where AbbVie Inc. (NYSE:ABBV) stands against the other pharma stocks. Healthcare takes the concept of ‘defensive’ further than almost any ...

Cencora (COR) announced that it has entered into a definitive agreement to acquire Retina Consultants of America, a management services organization of retina specialists, from Webster Equity ...

Drug distributor Cencora plans to buy Retina Consultants of America from Webster Equity Partners in a $4.6 billion deal. RCA is a management services organization that operates a network of retina ...

AbbVie has returned to the source of its antipsychotic powerhouse Vraylar in search of another blockbuster, paying $25 million upfront to form a new drug discovery pact with Gedeon Richter.

This month, we explore the 125-year-old history of Abbott Laboratories and its most significant milestone to date – the creation of its own independent company, AbbVie. In 1888, a 30-year-old ...

Nov 6 (Reuters) - Cencora (COR.N), opens new tab will buy Retina Consultants of America from private-equity firm Webster Equity Partners for $4.6 billion, the drug distributor said on Wednesday ...

Cencora's Q4 sales rose 14.7% to $79.1 billion, exceeding $77.65 billion consensus; adjusted EPS increased 16.8% to $3.34. The Retina Consultants of America deal will add nearly 300 retina ...

Cencora has a 52 week low of $184.00 and a 52 week high of $247.66. The firm’s 50-day simple moving average is $231.39 and its two-hundred day simple moving average is $230.60. 10 Stocks to Sell ...